Eczacıbaşı İlaç

Eczacıbaşı İlaç is a leading Turkish healthcare company and a core member of the Eczacıbaşı Group, established in 1942. The company operates across the pharmaceutical value chain, including the development, manufacturing, and marketing of prescription drugs, medical devices, and diagnostic products. A significant portion of its operations is conducted through its subsidiary, Eczacıbaşı Monrol, which is a global leader in the production of radiopharmaceuticals for nuclear medicine and molecular imaging. Eczacıbaşı İlaç also maintains strategic partnerships with international pharmaceutical firms to license and distribute innovative therapies within the Turkish market. The company is publicly traded on the Borsa Istanbul and is known for its high-standard manufacturing facilities in Lüleburgaz. Its therapeutic focus spans oncology, cardiovascular health, central nervous system disorders, and primary care.